Evidence map›Paper›PMID 12496189›Full record

ArticleInfection and immunity2003

CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum.

Todd G Smith, Lena Serghides, Samir N Patel, Maria Febbraio, Roy L Silverstein, Kevin C Kain

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00149383 (A Randomized, Double-blind, Placebo-controlled Trial of Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00149383 phase1 / phase2completednot on this mapstarted 2004, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Trial of Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection

TypeinterventionalSponsorMahidol UniversityRan2004 to 2006Enrolled140ConditionsFalciparum MalariaArmsRosiglitazone, Placebo
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Biology and epidemiology ofParasite epidemiology and control · 2023
    Review
  3. Review
  4. Review
  5. Review
  6. Management of cell death in parasitic infections.Seminars in immunopathology · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Host Cytoskeleton Remodeling throughout the Blood Stages of Plasmodium falciparum.Microbiology and molecular biology reviews : MMBR · 2019
    Review
  13. Review
  14. Review
  15. CD36 signaling in vascular redox stress.Free radical biology & medicine · 2019
    Review
  16. Immune Responses to the Sexual Stages ofFrontiers in immunology · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Todd G SmithDepartment of Medicine, University of Toronto, Toronto M5S 1A5, Ontario, Canada.
Lena Serghides
Samir N Patel
Maria Febbraio
Roy L Silverstein
Kevin C Kain
University of Toronto · CACornell University · USToronto General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gametocytes, the sexual stages of malaria parasites (Plasmodium spp.) that are transmissible to mosquitoes, have been the focus of much recent research as potential targets for novel drug and vaccine therapies. However, little is known about the host clearance of gametocyte-infected erythrocytes (GEs). Using a number of experimental strategies, we found that the scavenger receptor CD36 mediates the uptake of nonopsonized erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum by monocytes and culture-derived macrophages (Mphis). Light microscopy and immunofluorescence assays revealed that stage I and IIA gametocytes were readily internalized by monocytes and Mphis. Pretreating monocytes and Mphis with a monoclonal antibody that blocked CD36 resulted in a significant reduction in phagocytosis, as did treating GEs with low concentrations of trypsin to remove P. falciparum erythrocyte membrane protein 1 (PfEMP-1), a parasite ligand for CD36. Pretreating monocytes and Mphis with peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists, which specifically upregulate CD36, resulted in a significant increase in the phagocytosis of GEs. Murine CD36 on mouse Mphis also mediated the phagocytosis of P. falciparum stage I and IIA gametocytes, as determined by receptor blockade with anti-murine CD36 monoclonal antibodies and the lack of uptake by CD36-null Mphis. These results indicate that phagocytosis of stage I and IIA gametocytes by monocytes and Mphis appears to be mediated to a large extent by the interaction of PfEMP-1 and CD36, suggesting that CD36 may play a role in innate clearance of these early sexual stages.

Indexed as

Up-RegulationAnimalsCD36 AntigensCells, CulturedErythrocytesHumansMacrophages, PeritonealMalaria, FalciparumMiceMonocytesPhagocytosisPlasmodium falciparumReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsTranscription FactorsCD36 AntigensReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidRetinoid X ReceptorsTranscription FactorsTrypsin

Identifiers

PMID12496189
PMCPMC143147
OpenAlexW2102792995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.